We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Knee Revision System With Oxinium

By HospiMedica staff writers
Posted on 18 Jan 2006
A new knee revision system, used to replace or upgrade a total knee prosthesis, offers the potential for reduced operating time as well as additional durability.

Called Legion, the system has an oxidized zirconium (Oxinium) component that offers maximum biocompatibility and the potential for better performance. More...
The product of Smith & Nephew Orthopedics (Memphis, TN, USA), Legion is the only revision implant option on the market that addresses concerns of metal-sensitive patients. Oxinium has been shown to decrease polyethylene wear in laboratory testing and Legion has been modeled on Smith & Nephew's successful Genesis II knee system, which has been used in more than 500,000 surgeries worldwide.

Oxinium is created through a proprietary manufacturing process that enables zirconium to absorb oxygen and transform to a ceramic on the surface, resulting in a material that incorporates the best features of ceramic and metal while avoiding the limitations associated with either material. Oxinium is used in the production of components for knee and hip implants, where it exhibits superior performance characteristics due to its hardness, low-friction, and resistance to roughening and abrasion. Since 1995, more than 100,000 hip and knee components have incorporated Oxinium implants.

"The use of Oxinium makes Legion the only revision knee product with an advanced bearing material, and offers surgeons a new generation of surgical instruments that help reduce operating time and conserve the patient's bone,” said Scott Flora, senior vice president of Smith & Nephew's Reconstructive Division.




Related Links:
Smith & Nephew

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.